EVERYTHING
Dr. Eric J. Small addressed attendees at ASCO, framing scientific translation as a moral imperative for the global oncology community. According to Ascopost, he highlighted that while organizations like ASCO represent a massive collective force of over 50,000 members, their responsibility extends beyond discovery; it demands ensuring high-quality cancer care reaches every patient.
The Scope of Scientific Translation in Oncology
For Dr. Small, translation is not limited to linguistic interpretation but encompasses the entire journey from 'bench to bedside to society.' He stressed that clinical innovations must be successfully translated across multiple dimensions: languages, cultural contexts, geographical boundaries, and varying resource availability at practice sites.
This process requires careful attention to how complex scientific data is interpreted by both researchers and patients. Key elements that require translation include:
- Translating statistical metrics (such as P values and hazard ratios) into meaningful information for patients.
- Adapting treatment protocols so they are viable in low-resource settings globally.
- Ensuring the focus remains on patient quality of life, not just survival rates, especially when dealing with chemo-unresponsive diseases.
From Academic Discovery to Personal Responsibility
Dr. Small underscored that this commitment is deeply personal, citing the experience of losing his partner, Dr. Amy Lin, to a rare cancer. This loss intensified his belief in the collective moral duty of oncologists and researchers. He asserted that while scientific advances are crucial, there must be an unwavering focus on what truly matters to patients.
He called for the oncology community to:
- Double down on supporting the foundational science underpinning clinical advancements.
- Place patient needs at the forefront of all research and development efforts.
- Ensure that cancer advances are universally available, regardless of a patient's location or circumstance.
By emphasizing this holistic view of translation—connecting knowledge to meaning across diverse populations—Dr. Small concluded that the mission is clear: every patient, every cancer, everywhere must benefit from scientific progress.